HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane
Titel:
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane
Auteur:
Pohlmann, Paula R. Graham, Deena Wu, Tianmin Ottaviano, Yvonne Mohebtash, Mahsa Kurian, Shweta McNamara, Donna Lynce, Filipa Warren, Robert Dilawari, Asma Rao, Suman Mainor, Candace Swanson, Nicole Tan, Ming Isaacs, Claudine Swain, Sandra M.